David Matthew T
- SEC CIK
- 0001811612
No open-market purchases or sales filed in the past year.
Current role at each company
- CRMD CorMedix Inc.Chief Financial Officeras of Jan 14, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists David Matthew T as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 7, 2021 (view filing) | Dec 6 | 1 day | David Matthew TInterim CEO and CFO | PPurchase | +1.00K | $4.50 | +$4.50K | +46.5%3.15K after | Duplicate filing |
| Dec 7, 2021 (view filing) | Dec 6 | 1 day | David Matthew TInterim CEO and CFO | PPurchase | +1.00K | $4.50 | +$4.50K | +46.5%3.15K after | |
| Nov 19, 2021 (view filing) | Nov 17 | 2 days | David Matthew TInterim CEO and CFO | PPurchase | +1.00K | $5.07 | +$5.07K | +87.0%2.15K after |